WO2011067236A3 - Raltegravir-polymorphe - Google Patents
Raltegravir-polymorphe Download PDFInfo
- Publication number
- WO2011067236A3 WO2011067236A3 PCT/EP2010/068485 EP2010068485W WO2011067236A3 WO 2011067236 A3 WO2011067236 A3 WO 2011067236A3 EP 2010068485 W EP2010068485 W EP 2010068485W WO 2011067236 A3 WO2011067236 A3 WO 2011067236A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- raltegravir
- polymorphs
- novel polymorphs
- production
- relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- AIDS & HIV (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Die Erfindung betrifft neue Polymorphe von Raltegravir, Verfahren zu ihrer Herstellung und die neuen Polymorphe enthaltende pharmazeutische Formulierungen.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102009056636.8 | 2009-12-02 | ||
DE102009056636A DE102009056636A1 (de) | 2009-12-02 | 2009-12-02 | Raltegravir-Polymorphe |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2011067236A2 WO2011067236A2 (de) | 2011-06-09 |
WO2011067236A3 true WO2011067236A3 (de) | 2011-10-13 |
Family
ID=43606408
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2010/068485 WO2011067236A2 (de) | 2009-12-02 | 2010-11-30 | Raltegravir-polymorphe |
Country Status (2)
Country | Link |
---|---|
DE (1) | DE102009056636A1 (de) |
WO (1) | WO2011067236A2 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2762339B1 (de) | 2013-02-04 | 2016-04-06 | C.R.F. Società Consortile per Azioni | Hybridantriebsstrang für Kraftfahrzeug |
EP2957445B1 (de) | 2014-06-17 | 2016-09-14 | C.R.F. Società Consortile per Azioni | Hybridantriebsstrang für Kraftfahrzeuge mit Eingriffsvorrichtungen auf gegenüberliegenden Seiten des Elektromotors |
EP2957447B1 (de) | 2014-06-17 | 2016-09-14 | C.R.F. Società Consortile per Azioni | Hybridantrieb für Kraftfahrzeuge mit Hilfsvorrichtungen |
EP2957444B1 (de) | 2014-06-17 | 2016-09-14 | C.R.F. Società Consortile per Azioni | Hybridantrieb für Kraftfahrzeuge mit einer Riemengetriebevorrichtung zwischen Elektromotor und Differenzial |
EP2957446B1 (de) | 2014-06-17 | 2016-09-14 | C.R.F. Società Consortile per Azioni | Hybridantriebseinheit für Kraftfahrzeuge mit einer Vorrichtung zur Übertragung an eine weitere Achse des Kraftfahrzeuges |
EP2979911B1 (de) | 2014-07-29 | 2016-09-21 | C.R.F. Società Consortile per Azioni | Hybridantrieb für Kraftfahrzeuge mit variabler Getriebevorrichtung zwischen elektrischer Maschine und Differenzial |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA007060B1 (ru) | 2001-10-26 | 2006-06-30 | Иституто Ди Ричерке Ди Биолоджиа Молеколаре П. Анджелетти Спа | N-замещённые гидроксипиримидинон-карбоксамидные ингибиторы вич интегразы |
UA87884C2 (uk) | 2004-12-03 | 2009-08-25 | Мерк Энд Ко., Инк. | Безводна кристалічна калієва сіль інгібітора віл-інтегрази |
-
2009
- 2009-12-02 DE DE102009056636A patent/DE102009056636A1/de not_active Withdrawn
-
2010
- 2010-11-30 WO PCT/EP2010/068485 patent/WO2011067236A2/de active Application Filing
Non-Patent Citations (2)
Title |
---|
"Crystalline Form of N-(2-(4-(4-fluorobenzylcarbamoyl) 5-hydroxy-1-methyl-6- oxo-1, 6-dihydropyrimidin-2-yl)propan-2-yl) 5-methyl-1,3,4-oxadiazole-2- carboxamide", IP.COM JOURNAL, IP.COM INC., WEST HENRIETTA, NY, US, 14 January 2010 (2010-01-14), XP013136412, ISSN: 1533-0001 * |
SUMMA VINCENZO ET AL: "Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, WASHINGTON, US, vol. 51, no. 18, 25 September 2008 (2008-09-25), pages 5843 - 5855, XP002615638, ISSN: 0022-2623, [retrieved on 20080903], DOI: DOI:10.1021/JM800245Z * |
Also Published As
Publication number | Publication date |
---|---|
WO2011067236A2 (de) | 2011-06-09 |
DE102009056636A1 (de) | 2011-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010122578A3 (en) | Process for preparation of sitagliptin and its intermediates | |
ZA201001015B (en) | (Carboxylalkylene-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament | |
IL204556A0 (en) | (cyclopropyl-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament | |
WO2010031720A3 (en) | Novel antibody formulation | |
IL216337A (en) | Pirazinyl compounds, a process for their preparation, preparations containing them and their uses | |
EP2170798A4 (de) | Verfahren mit hoher scherung zur herstellung von acetaldehyd | |
EP2406381A4 (de) | Herstellung eines fermentativen endprodukts aus clostridium sp. | |
WO2010015657A3 (en) | Alkoxypyrazoles and the process for their preparation | |
EP2412706A4 (de) | Neues hydroxamatderivat, verfahren zu seiner herstellung und pharmazeutische zusammensetzung damit | |
WO2011046303A3 (en) | Novel method for preparing entecavir and intermediate used therein | |
WO2012070062A3 (en) | Novel polymorph of nilotinib hydrochloride | |
WO2010102778A3 (de) | Substituierte 3-aminoisoxazolopyridine als kcnq2/3 modulatoren | |
WO2009115084A3 (de) | Pyrrolopyrimidin-derivate und deren verwendungen | |
WO2011009938A3 (en) | Stambomycin and derivatives, their production and their use as drugs | |
WO2011067236A3 (de) | Raltegravir-polymorphe | |
WO2011058525A3 (en) | Processes for the preparation of erlotinib hydrochloride form a and erlotinib hydrochloride form b | |
WO2011069032A3 (en) | Formulations, salts and polymorphs of transnorsertraline and uses thereof | |
WO2010015656A3 (en) | Alkoxypyrazoles and the process for their preparation | |
WO2010079045A3 (en) | Crystalline salt forms of flibanserine | |
WO2011018771A3 (en) | Process for the preparation of valganciclovir hydrochloride | |
WO2011023954A3 (en) | Polymorphic forms of manidipine | |
WO2010121877A3 (en) | Process for the preparation of olopatadine | |
WO2010039885A3 (en) | Crystalline forms of dexlansoprazole | |
IL211062A0 (en) | Pharmaceutical uses of lanosta-8,24-dien-3-ols | |
MX2011006721A (es) | Formulacion farmaceutica de fenofibrato nanonizado. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10785062 Country of ref document: EP Kind code of ref document: A1 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 10785062 Country of ref document: EP Kind code of ref document: A2 |